EN | ES
Salvat
  • Salvat
  • Activities
  • Partnering & Services
  • Products
  • Commitment
  • Careers
  • Media
  • Connect
  • Menu

Salvat’s News and Press kit

Media

Salvat at a glance

Press Kit

What are we doing right now

News

Media

Press Kit

Salvat at a glance

If you are a media professional and wish to receive more information, please send us an email at media@svt.com.

YOU CAN DOWNLOAD OUR PRESS KIT HERE:

SALVAT PRESS KIT

English Version PDF

Download

News

What are we doing right now

Salvat Laboratory submits application to the U.S. FDA for approval of Clotrimazole, a pioneering drug for the treatment of otomycosis

01/12/2022/in Salvat International, Salvat Spain, Salvat USA /by Carme Lopez

The new drug will be the only one on the market in the United States and Europe specifically formulated and indicated for the topical treatment of fungal otitis externa. Salvat has invested 22 million euros in this project with which reinforces its position as a leading laboratory in the field of otology at an international […]

Read more
https://svt.com/wp-content/uploads/2017/12/salvat-logo-263x68.png 0 0 Carme Lopez https://svt.com/wp-content/uploads/2017/12/salvat-logo-263x68.png Carme Lopez2022-12-01 08:43:002022-12-01 08:43:00Salvat Laboratory submits application to the U.S. FDA for approval of Clotrimazole, a pioneering drug for the treatment of otomycosis

Salvat Laboratory obtains the qualification “Excellent” in the PROFARMA program

28/10/2022/in Salvat Spain /by Carme Lopez

Salvat is one of the top-rated pharmaceutical companies that has achieved the best rating in the PROFARMA program, among the 49 evaluated by the Ministry of Industry, Trade and Tourism. The PROFARMA Plan seeks to increase the competitiveness of the industry through the modernization of the sector and the enhancement of activities that provide greater […]

Read more
https://svt.com/wp-content/uploads/2017/12/salvat-logo-263x68.png 0 0 Carme Lopez https://svt.com/wp-content/uploads/2017/12/salvat-logo-263x68.png Carme Lopez2022-10-28 08:13:292022-11-21 14:54:27Salvat Laboratory obtains the qualification "Excellent" in the PROFARMA program

Salvat Laboratories announces submission of New Drug Application to the U.S. FDA for Clobetasol Nanoemulsion for treating inflammation and pain after ocular surgery

25/10/2022/in Salvat International, Salvat Spain, Salvat USA /by Carme Lopez

Salvat Laboratories, the international company which developed and owns the globally commercialized products Otovel and Cetraxal, today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the approval of the first ocular corticosteroid formulated in a nanoemulsion for inflammation and pain in post-ocular surgery patients. […]

Read more
https://svt.com/wp-content/uploads/2017/12/salvat-logo-263x68.png 0 0 Carme Lopez https://svt.com/wp-content/uploads/2017/12/salvat-logo-263x68.png Carme Lopez2022-10-25 12:19:472022-10-25 12:19:47Salvat Laboratories announces submission of New Drug Application to the U.S. FDA for Clobetasol Nanoemulsion for treating inflammation and pain after ocular surgery

Salvat, pioneer in using cell-therapy for the treatment of non-consolidated bone fractures (BONECURE project)

07/09/2022/in Salvat International, Salvat Spain, Salvat USA /by Carme Lopez

It is an innovative project based on pre-differentiated mesenchymal stem cells designed to treat patients with bone consolidation problems post-fracture (atrophic pseudoarthrosis). A Phase II clinical trial has been completed, with very promising results in terms of efficacy and safety, in patients with pseudoarthrosis of long bones. Salvat has invested more than 10 million Euros […]

Read more
https://svt.com/wp-content/uploads/2017/12/salvat-logo-263x68.png 0 0 Carme Lopez https://svt.com/wp-content/uploads/2017/12/salvat-logo-263x68.png Carme Lopez2022-09-07 13:11:572022-09-07 13:11:57Salvat, pioneer in using cell-therapy for the treatment of non-consolidated bone fractures (BONECURE project)

Salvat plans to launch the first global ocular corticosteroid with nanoemulsion in 2023 for the inflammation and pain after ocular surgery

21/04/2022/in Salvat International, Salvat Spain, Salvat USA /by Carme Lopez

Phase III clinical trials conducted in US confirm that clobetasol is effective and safe in the treatment of inflammation and pain after cataract surgery. The pharmaceutical company has begun the process with health authorities to market the new corticosteroid worldwide by the middle of next year. The company has patented a pioneering technology, IMPACT-SVT®, which […]

Read more
https://svt.com/wp-content/uploads/2017/12/salvat-logo-263x68.png 0 0 Carme Lopez https://svt.com/wp-content/uploads/2017/12/salvat-logo-263x68.png Carme Lopez2022-04-21 14:46:312022-04-21 14:54:24Salvat plans to launch the first global ocular corticosteroid with nanoemulsion in 2023 for the inflammation and pain after ocular surgery
Page 2 of 7‹1234›»

CATEGORIES

  • Salvat Foundation
  • Salvat International
  • Salvat Spain
  • Salvat USA

LATEST NEWS

  • Jordi Muntañola, new CEO of the Salvat Pharmaceutical Group12/02/2025 - 3:11 pm

    A new phase begins for the Salvat Pharmaceutical Group, comprised of Laboratorios Salvat, Pharmaloop, and Salvat USA. The pharmaceutical company has appointed Jordi Muntañola as the new Chief Executive Officer (CEO). With an international leadership profile and over 20 years of experience in the pharmaceutical industry, Muntañola takes on the role with the aim of […]

  • Salvat becomes the first Spanish pharmaceutical company to receive FDA approval for sterile drug manufacturing using BFS technology15/10/2024 - 8:04 am

    The pharmaceutical company Salvat has received FDA approval to manufacture Otovel, an ear drop solution for the treatment of acute otitis media, at its Pharmaloop facility in Alcalá de Henares for distribution in the U.S. market. In addition to Otovel, Salvat is expected to produce three more products from its otolaryngology and ophthalmology lines for […]

  • Laboratorios Salvat strengthens its commitment to those affected by glaucoma by meeting their specific needs12/03/2024 - 2:53 pm

    The pharmaceutical company and the Glaucoma Association for People Affected and Families (AGAF) in collaboration and endorsed by the Spanish Glaucoma Society will publish the book ‘The 101 doubts about Glaucoma that you always wanted to know and did not dare to ask’. The laboratory thus reaffirms its presence in the field of ophthalmology to […]

  • Salvat
  • Mission, Vision & Values
  • The Company
  • Our History
  • Salvat USA
  • Salvat Worldwide
  • Our People
  • Activities
  • R+D
  • Product Pipeline
  • Partnering
  • Manufacturing
  • Pharmaloop
  • Sales
  • Partnering & Services
  • Licensing and Partnership
  • CDMO Services
  • Innovation and Technology
  • Meet Us
  • Products
  • Otolaryngology
  • Ophthalmology
  • Gastroenterology
  • Other Therapeutic Areas
  • Consumer Healthcare
  • Full Product List
  • Commitment
  • Corporate Citizenship
  • Transparency
  • Memberships
  • Salvat Foundation
  • Careers
  • Working at Salvat
  • Send your CV
  • Media
  • Press Kit
  • News
  • Connect
  • Contact Us
  • Salvat Replies
  • Disclaimer
  • Cookies
  • © Salvat 2020, All Rights Reserved
  • Twitter
  • Linkedin
  • Facebook

Usamos 'cookies' para personalizar el contenido y analizar el uso de nuestro sitio web. Si hace clic en "Aceptar", da su consentimiento para el uso de éstas y navegará directamente a la página web. Si no quiere aceptar algunas de las ‘cookies’ o quiere saber más acerca de cómo usamos las ‘cookies’, haga click en “Personalizar”.

VER POLÍTICA DE  COOKIES


We use 'cookies' to personalize content and analyze the use of our website. By clicking "I Accept", you consent to their use and will navigate directly to the website. If you do not want to accept some of the ‘cookies’ or want to know more about how we use the ‘cookies, click on“ Personalize”.

VIEW COOKIES POLICY

ACEPTAR / I ACCEPTPERSONALIZAR / PERSONALIZE

RECHAZAR / REJECT

Manage consent

Personalizar / Personalize

Aquí puede elegir las cookies que se guardan en su navegador:
Here you can select the cookies allowed to be stored on your browser:
Analytics
These cookies collect information about how visitors make use of the website, such as page views, loading errors… It is generic and anonymous information where personal data are not included nor collects information that identifies visitors; with the ultimate aim to improve the functioning of the website.

CookieDurationDescription
_ga2 yearsGoogle Analytics
_gat_gtag_UA_112188601_12 yearsGoogle Analytics
_gid2 yearsGoogle Analytics
Necessary
Always Enabled
These cookies are necessary for the proper use of the website, allowing access to sections that have security filters. Without these cookies, many of the features would not be operating.
CookieDurationDescription
cookielawinfo-checbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
ip2location_redirection_first_visitsessionMostrar las páginas de la web en el idioma seleccionado / Browse this website pages in the selected language
PHPSESSIDsessionIdentificador de sesión PHP / PHP session id
prescriptionModalAcceptedsessionIdentificador de sesión PHP / PHP session id
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
wpml_browser_redirect_testsessionMostrar las páginas de la web en el idioma seleccionado / Browse this website pages in the selected language
_icl_visitor_lang_jssessionMostrar las páginas de la web en el idioma seleccionado / Browse this website pages in the selected language
SAVE & ACCEPT
  Scroll to top